Limited Impact of High Bleeding Risk Calculation and Peri-Procedural Discussion on Dual-Antiplatelet Therapy Duration and Clinical Outcomes After Percutaneous Coronary Intervention
Background: The Japanese version of the high bleeding risk (J-HBR) criteria identifies patients with HBR undergoing percutaneous coronary intervention (PCI). We evaluated whether routine J-HBR calculation and peri-procedural discussion on dual-antiplatelet therapy (DAPT) duration were associated with changes in DAPT practice and clinical outcomes.
Authors
- Mikito Takefuji (ORCID: https://orcid.org/0000-0003-4870-7913)
- Tomoaki Nawano
- Hideo Oishi
- Yasuhiro Ogura (ORCID: https://orcid.org/0000-0001-5768-6160)
- Ruka Yoshida (ORCID: https://orcid.org/0000-0002-1693-7389)
- Ryo Watanabe (ORCID: https://orcid.org/0000-0002-7444-2624)
- Monami Ando
- Kenshi Hirayama
- Hirohiko Suzuki
- Shunsuke Ito
- Shu Sobue
- Yukihiko Yoshida
- Tomoki Hattori
- Toyoaki Murohara
- Ryo Ibayashi
Institutions
- Japanese Red Cross Nagoya Daini Hospital (JP)
- Nagoya University (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2026-09-18
- DOI
- https://doi.org/10.1253/circrep.cr-26-0135
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00